One of the key considerations for a new innovation centers on intellectual property (IP). This is the first part of a two-part mini-series on IP with an initial focus on technology transfer
The 2019 American Academy of Dermatology (AAD) Meeting in Washington, D.C., is always a wonderful reminder of all of the innovation happening in dermatology. I left the meeting optimistic that our field is moving forward with new disease insights, new therapies, and new diagnostics driven forward by motivated, talented individuals across academia and industry.
Biopharmaceutical companies and their partners are taking a page from Silicon Valley by sponsoring hackathons and competitions to drive innovation in research and develop new solutions for patients.
Industry relationships are essential for innovation in dermatology. In this month’s column, Steve Xu, M.D., and Michael L. Sierra, Ph.D., provide their insight on collaborating with industry.
For the sixth year in a row, JPM week kicked off with the Dermatology Summit at the Palace Hotel in San Francisco. Organized by Advancing Innovation in Dermatology (AID), the conference included expert industry insights and a variety of panel discussions, fireside chats and networking events. Included in the events was a Leadership Sponsor Pane
What exactly is digital health? The scope and definition of digital health is broadening and now, it seems, digital health is essentially anything that isn’t a drug or traditional medical device.
Advancing Innovation in Dermatology (AID), Hacking Medicine Institute (HMi), and LEO Science & Tech Hub, the Boston-based R&D innovation unit of LEO Pharma, officially announce the final winners of Hacking Dermatology. Awardees include Lucid, a personalized and automated home patch testing solution, RxThat, an online prescription marketplace and management application, and MatchLab, a skin-image analysis
Successful innovation requires an intimate understanding of underlying unmet clinical needs.